USE OF IMMUNE DIVERSITY AS A PREDICTIVE MARKER FOR IDENTIFYING B-CELL-LYMPHOMAS-PATIENTS HAVING AN INCREASED RISK OF FEBRILE OR INFECTIOUS EVENT
摘要
<p>The present invention pertains to the field of cancer therapy and provides a predictive marker for determining if a patient suffering from a B-cell neoplasm can benefit from an anti-CD20-based immunotherapy.</p>
申请公布号
WO2016009415(A1)
申请公布日期
2016.01.21
申请号
WO2015IB55491
申请日期
2015.07.20
申请人
IMMUNID
发明人
FILIPE SANTOS, ORCHIDÉE;PASQUAL, NICOLAS;COURTIER, ANAÏS;WEISBUCH, SÉBASTIEN;MOURET, JEAN-FRANÇOIS
